2-Bromoacetyl-4-ethylpyridine → Methyl[2-(4-ethylpyridine-2-carbonyl)-5-trifluoromethoxy-1h-indol-3-yl]acetate
Reaktionsgleichung
C1(C)C=CC(S([NH:10][C:11]2[CH:22]=[CH:21][C:20]([O:23][C:24]([F:27])([F:26])[F:25])=[CH:19][C:12]=2/[CH:13]=[CH:14]/[C:15]([O:17][CH3:18])=[O:16])(=O)=O)=CC=1.Br[CH2:30][C:31]([C:33]1[CH:38]=[C:37]([CH2:39][CH3:40])[CH:36]=[CH:35][N:34]=1)=[O:32]>>[CH3:18][O:17][C:15](=[O:16])[CH2:14][C:13]1[C:12]2[C:11](=[CH:22][CH:21]=[C:20]([O:23][C:24]([F:25])([F:26])[F:27])[CH:19]=2)[NH:10][C:30]=1[C:31]([C:33]1[CH:38]=[C:37]([CH2:39][CH3:40])[CH:36]=[CH:35][N:34]=1)=[O:32]Komponenten
3
Versuchsvorschrift
The title compound was prepared according to the procedure described in Example 57 from methyl trans-2-p-toluenesulfonylamino-5-(trifluoromethoxy)cinnamate (step 2 of Example 145) and 2-bromoacetyl-4-ethylpyridine (Preparation is described in Example 57).
Quellen und Nachweise
- ORD-Eintrag
- ord-88e2dc5bfef94fd5999160405cf22f1c
- Quelldatensatz
- uspto-grants-2003_08